|
|
|
|
DuoCort: New Chronotherapy For Adrenal Insufficiency
DuoCort publishes data from its Phase I study for the rare and life threatening disease adrenal insufficiency.The release profile of DuoCort's new form of treatment with once-a-day hydrocortisone dosing closely resembles the physiological...
|
|
|
DuoCort AB: New Chronotherapy For Adrenal Insufficiency
Helsingborg, Sweden, June 29th 2009 / b3c newswire / - DuoCort publishes data from its Phase I study for the rare and life threatening disease adrenal insufficiency.The release profile of DuoCorts new form of treatment with once-a-day...
|
|
|
Diagnosis of Acute Mitral Valve Insufficiency Using Emergency Bedside Echocardiography
Jeremy Sautner, MD and Gavin Budhram, Medical Center, Department of Emergency Medicine, Springfield, MA 2009 Society for ABSTRACTNo AbstractDIGITAL OBJECT IDENTIFIER (DOI)10.1111/j.1553-2712.2009.00449.x Related Find other like this in Find...
|
|
|
Study Defines Strategy to Protect Bones in Women, Girls With Primary Ovarian Insufficiency
-- Delayed diagnosis of a primary ovarian insufficiency premature, menopause-like condition, may make women more susceptible to osteoporosis and fractures later in life, according to new research by scientists at the National Institutes of...
|
|
|
Study Defines Strategy to Protect Bones in Women, Girls With Primary Ovarian Insufficiency
-- Delayed diagnosis of a primary ovarian insufficiency premature, menopause-like condition, may make women more susceptible to osteoporosis and fractures later in life, according to new research by scientists at the National Institutes of...
|
|
|
Placebo therapy program shows potential effectiveness in future clinical trials
Submit a Comment A placebo therapy program effectively maintained patient masking and showed potential utility for future clinical trials, according to a study.Investigators evaluated the Convergence Insufficiency Treatment Trial...
|
|
|
DuoCort AB: Successful Phase II/III Trial Of New Therapy For Adrenal Insufficiency
Helsingborg Sweden/ Washington DC June 12th 2009 / b3c newswire / - DuoCort gained promising data from its Phase II/III study for the rare and life threatening disease adrenal insufficiency.DuoCorts new form of physiological treatment...
|
|
|
Minimally Invasive Stent Treatment Aids Chronic Venous Insufficiency
During circulation, arteries carry oxygen-rich blood from the heart to the limbs (and other parts of the body) and veins return oxygen-poor blood to the heart.Disease of the limb arteries is commonly referred to as PAD (peripheral...
|
|
|
Minimally Invasive Stent Treatment Aids Chronic Venous Insufficiency
Also contributing to the development of CVI can be being overweight or pregnant, lack of exercise, or standing or sitting for a long time without much leg movement.Elderly patients who are sedentary and prone to relative immobility are...
|
|
|
Stenting Yields Unexpected Benefits in Chronic Venous Insufficiency
Stenting in iliac veins can drastically alleviate the symptoms of chronic venous insufficiency (CVI) by addressing the underlying obstructive deep vein lesions found in many of the patients with the condition, according to new data presented...
|
|
|
Hyperuricemia, Oxidative Stress, and Carotid Artery Tone in Experimental Renal Insufficiency
Venla Kurra, Arttu Erranta, Pasi Jolma,, Tuija I.Vehmas, Asko Riutta, Eeva Moilanen, Anna Tahvanainen, Jarkko Kalliovalkama, Onni Niemel, Juhani Myllymki,, Jukka Mustonen, and Ilkka Prsti,Medical School, University of Tampere, Tampere,...
|
|
|
Minimally Invasive Stent Treatment Aids Chronic Venous Insufficiency
During their report Friday at the 63rd Annual Meeting of the Society for Vascular Surgery, Seshadri Raju, M.D., FACS, and other researchers from the University of Mississippi in Jackson offered details about how many patients with severe...
|
|
|
Protea Announces Drug Development Partnership With Mayoly Spindler, a European Pharmaceutical Company
The Two Companies Will Collaborate in the Development of a New Biopharmaceutical for the Treatment of Exocrine Pancreatic Insufficiency (EPI) Clinical Trials Commence in Early 2010 MORGANTOWN, W.Va., May 29, 2009 (GLOBE NEWSWIRE)...
|
|
|
Protea Announces Drug Development Partnership With Mayoly Spindler, a European Pharmaceutical Company
The Two Companies Will Collaborate in the Development of a New Biopharmaceutical for the Treatment of Exocrine Pancreatic Insufficiency (EPI) Clinical Trials Commence in Early 2010 MORGANTOWN, W.Va., May 29, 2009 (GLOBE NEWSWIRE)...
|
|
|
Protea Announces Drug Development Partnership With Mayoly Spindler, a European Pharmaceutical Company
The Two Companies Will Collaborate in the Development of a New Biopharmaceutical for the Treatment of Exocrine Pancreatic Insufficiency (EPI) Clinical Trials Commence in Early 2010 MORGANTOWN, W.Va., May 29, 2009 (GLOBE NEWSWIRE)...
|
|
|
Chronic Venous Insufficiency and Varicose Veins
_ Chronic Venous Insufficiency and Varicose Veins.
|
|
|
Current Concepts: Predisposing Factors for Adrenal Insufficiency
_ Current Concepts: Predisposing Factors for Adrenal Insufficiency.
|
